Powder Delivery TRIZ Cases

Anti-periostin antibody immunoassays measure periostin levels to guide IL-13 antagonist therapy, avoiding corticosteroid side effects.

Nanoscale metal oxide fillers provide X-ray opacity in dental infiltrants while maintaining low viscosity for deep enamel penetration.

A carbonaceous material loaded with metal particles targets gastric cancer cells to inhibit growth.

Extracted fatty acids and sterols from Acrocomia crispa address chronic inflammation without synthetic drug adverse effects.

Fabimycin overcomes outer membrane barriers and efflux pumps to accumulate inside Gram-negative pathogens and inhibit bacterial fatty acid biosynthesis.

Block polymers form nanoparticles with targeted moieties to reduce unwanted side effects from non-specific drug distribution.

Segmenting anticancer agents into crosslinked micelles reduces healthy cell toxicity while maintaining therapeutic effectiveness.

Segmenting cross-linked fatty acids via cryogenic processing enables targeted delivery, improving bioavailability while minimizing inflammatory responses.

Pyridine and pyrimidine compounds inhibit Bruton's tyrosine kinase via covalent warhead binding to the C481 residue, reducing off-target effects.

Universal nanoparticle platforms combine with specific recognition groups to degrade proteins across the blood-brain barrier.

Embolization particles use a core-shell polymer gradient to resolve size uniformity and density contradictions.

Salt walls form via Lewis acid-base reaction at droplet interfaces to encapsulate water-immiscible core materials.

Short-chain fatty acids improve intestinal health, enabling effective tryptophan absorption from alpha-lactalbumin in weak digestive systems.

A temperature-sensitive composite uses Pluronic F-127 and sodium hyaluronate to maintain liquid state at room temperature.

Comminuting dried curcuminoids prevents aggregation in water, resolving solubility issues for comestible applications.

Ionizable second network swells within first network to increase physical cross-links, resolving mechanical strength versus hydrophilicity trade-off.

A biodegradable dextran coating prevents nanoceria agglomeration in water, resolving the trade-off between colloidal stability and antioxidant potency.

A pharmaceutical composition using grape powder and seed extract to treat lung injury.

Phospholipid shells enhance photostability and hydrophilicity while antibodies enable specific cancer targeting.

Segmented ECM proteins and parameter-controlled polymer backbones eliminate surgical removal needs by ensuring natural degradation.

Segmented polymer scaffolds enable temporal control over growth factor release, preventing rapid diffusion from bone defect sites.

Liquid aerosol conditioning in jet milling produces stable particles with controlled size distribution.

Atomized protein droplets collect in a mixed dehydration solvent to generate microparticles with high specific activity.

Formula-I compounds inhibit phosphodiesterase enzymes, offering a safer alternative to corticosteroids for treating psoriasis and dermatitis.

Thiolene-click crosslinking forms functionalized polycarbonate nanoparticles with controlled sizes, enabling precise drug delivery systems.

I-BRD9 bromodomain inhibitor reduces seizure levels and postpones convulsion onset, addressing side effects of conventional antiepileptic drugs.

Lectins bind specific glycans to label and isolate cancer stem cells, resolving detection precision issues caused by low cell abundance.

Silk fibroin hydrogel releases antibiotics locally to prevent infection and side effects from systemic treatment.

Saponification of carotenoid oleoresins yields non-esterified xanthophyll particles with high all-trans isomer concentration.

Replacing oxygen groups with sulfur moieties improves brain extraction efficiency and kinetic properties for accurate neurodegeneration imaging.

A laminated film bonds gastric and enteric layers via an acidic solution to achieve controlled ingredient release.

Hot-melt extrusion forms a decoquinate solid solution, resolving poor solubility and bioavailability trade-offs.

A silicone-based needle coating formulation reduces insertion forces through lubrication.

Lyophilized esmolol hydrochloride powder reconstitutes into high-concentration intravenous solutions without alcohol or buffer excipients.

Peptide-based antiviral prodrugs self-assemble into supramolecular hydrogels upon injection to encapsulate therapeutic agents.

Multi-arm PEG modifiers prevent subunit depolymerization of L-asparaginase, extending in vivo half-life while maintaining protein activity.

A composite dietary supplement binds ionic heavy metals through ion exchange mechanisms.

Dissolving oral strips target the vestibular mucosa to prolong allergen contact time and reduce localized side effects.

A hydrophobic matrix forms a paste-like drug delivery composition via mechanical mixing to sustain release of active compounds.

Cationic lipid-nucleic acid salts dissolve in organic solvents to enable targeted intracellular delivery of therapeutic agents.

A lyophilized amorphous phenobarbital sodium composition maintains high purity through controlled freeze-drying and precise pH adjustment.

Histidine buffers stabilize high concentration C1-INH formulations, preventing aggregation during long-term storage.

A pharmaceutical composition combines D-mannose, proanthocyanidins, hydroquinone derivatives, and zinc to inhibit bacterial adhesion.

Nanoparticles crosslink recombinant proteins via disulfide bonds to form stable carriers.

Injectable varenicline depot formulation maintains stable blood concentrations over weeks, reducing dosing frequency and nausea.

Non-covalent attachment of polynucleotides to a polydopamine shell enables specific miRNA detection in live stem cells while maintaining probe stability.

Sequential dosing of non-gelling and gelling matrix agents prevents surface deformations during freeze-drying, maintaining structural integrity.

C-6 substituted estradiol derivatives up-regulate lipoprotein lipase expression to promote anti-inflammatory microglial phenotypes.

Pre-conjugating phenolic compounds to polymer carriers protects them from rapid metabolism and extends bioavailability through triggered degradation.

Agent-loaded nanoparticles conjugated to virus-specific T cells deliver therapeutic agents directly to infected tissues.